A Role of JAK/STAT Pathway in Cutaneous T-Cell Lymphomas: Exploring Its Effects for Targeted Therapy

被引:0
|
作者
Perez, Cristina [1 ]
Gonzalez-Rincon, Julia [2 ]
Almaraz, Carmen [1 ]
Curiel, Soraya [1 ]
Garcia, Nuria [1 ]
Pisonero, Helena [1 ]
Gomez, Sagrario [2 ]
Cereceda, Laura [1 ]
Onaindia, Arantza [3 ]
Madureira, Rebeca [1 ]
Leon, Alicia [3 ]
Gonzalez-Vela, Carmen [3 ]
Ortiz-Romero, Pablo L. [4 ]
Martinez, Nerea [1 ]
Sanchez-Beato, Margarita [2 ]
Vaque, Jose Pedro [1 ]
Piris, Miguel Angel A. [5 ]
机构
[1] Inst Invest Marques de Valdecilla IDIVAL, Santander, Spain
[2] Inst Invest Puerta de Hierro, Madrid, Spain
[3] Hosp Marques de Valdecilla, Santander, Spain
[4] Hosp Univ Doce de Octubre, Madrid, Spain
[5] Hosp Marques de Valdecilla, Santander, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Exploring the role of JAK inhibitors in Cutaneous T-cell Lymphoma
    Kashyap, A.
    Ni, X.
    Dai, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S179 - S179
  • [2] Targeted therapies for cutaneous T-cell lymphomas
    Kaplan, Jason B.
    Guitart, Joan
    Giles, Francis J.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (04) : 481 - 493
  • [3] New Targeted Treatments for Cutaneous T-cell Lymphomas
    Bagot, Martine
    INDIAN JOURNAL OF DERMATOLOGY, 2017, 62 (02) : 142 - 145
  • [4] Cutaneous T-Cell Lymphomas - under targeted Therapy with Brentuximab Vedotin and Mogamulizumab
    Bartels, P.
    Debus, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 51 - 51
  • [5] THERAPY WITH AROTINOID IN CUTANEOUS T-CELL LYMPHOMAS
    THIELE, B
    MAHRLE, G
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1984, 276 (04) : 262 - 262
  • [6] COMBINED THERAPY FOR CUTANEOUS T-CELL LYMPHOMAS
    NISCE, LZ
    SAFAI, B
    ONG, R
    KEMPIN, S
    POUSSIN, HR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (09): : 1241 - 1242
  • [7] Radiation Therapy for Cutaneous T-Cell Lymphomas
    Tandberg, Daniel J.
    Craciunescu, Oana
    Kelsey, Chris R.
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 703 - +
  • [8] INVESTIGATIONS AND THERAPY OF CUTANEOUS T-CELL LYMPHOMAS
    LE, T
    PIERARD, GE
    PIERARDFRANCHIMONT, C
    DELABRASSINNE, M
    LAPIERE, CM
    DERMATOLOGICA, 1984, 169 (02): : 60 - 65
  • [9] Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway
    Lee, Katie
    Evans, Mark G.
    Yang, Lei
    Ng, Spencer
    Snowden, Caroline
    Khodadoust, Michael
    Brown, Ryanne A.
    Trum, Nicholas A.
    Querfeld, Christiane
    Doan, Linda T.
    Song, Jinming
    Zhang, Hailing
    Gru, Alejandro A.
    Wood, Gary S.
    Wada, David A.
    Shanmugam, Vignesh
    Haun, Paul L.
    Aster, Jon C.
    Duncan, Lyn M.
    Guitart, Joan
    Weinstock, David M.
    Nardi, Valentina
    Choi, Jaehyuk
    BLOOD, 2021, 138 (23) : 2435 - 2440
  • [10] Identification of novel candidate genes for targeted therapy of primary cutaneous T-cell lymphomas
    Ranki, A.
    Hahtola, S.
    Tuomela, S.
    Burghart, E.
    Elo, L.
    Karenko, L.
    Krohn, K.
    Lahesmaa, R.
    Monni, O.
    Klein, C.
    EJC SUPPLEMENTS, 2006, 4 (12): : 126 - 126